Global Exocrine Pancreatic Insufficiency (EPI) Therapeutics and Diagnostics Market Poised to Gain Steady Boost at CAGR of 7.2% Through 2025
The rising prevalence of exocrine pancreatic insufficiency around the world has created significant demand for effective treatment methods. It has been analyzed that EPI results due to a number of conditions such as cystic fibrosis, cytomegalovirus infection, pancreatic cancer, chronic pancreatitis, and HIV/AIDS. Owing to the alarming increase in the prevalence of cystic fibrosis, the risk of EPI also increases substantially. These facts have resulted for market growth of EPI therapeutics and diagnostic widely, finds a new study published to...
View full press release